(Q35112648)

6 August 2017

1 reference

title

Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients (English)

1 reference

6 August 2017

Positron emission tomography with [18F]FDG for therapy response monitoring in lymphoma patients (English)

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00259-003-1166-5

26 December 2023

3

Gregor Verhoef

0 references

Sigrid G. Stroobants

series ordinal

2

object named as

Sigrid Stroobants

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709831

26 December 2023

author name string

Karoline Spaepen

series ordinal

1

1 reference

6 August 2017

Luc Mortelmans

series ordinal

4

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12709831

26 December 2023

publication date

23 April 2003

1 reference

full work available at URL

6 August 2017

http://link.springer.com/content/pdf/10.1007/s00259-003-1166-5.pdf

file format

Portable Document Format

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00259-003-1166-5

http://link.springer.com/article/10.1007/s00259-003-1166-5/fulltext.html

26 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00259-003-1166-5

http://link.springer.com/content/pdf/10.1007/s00259-003-1166-5

26 December 2023

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00259-003-1166-5

European Journal of Nuclear Medicine and Molecular Imaging

26 December 2023

published in

1 reference

6 August 2017

30 Suppl 1

1 reference

6 August 2017

S97-105

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-003-1166-5

6 August 2017

0 references

cites work

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

12 December 2020

Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease

1 reference

12 December 2020

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

1 reference

12 December 2020

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging

1 reference

12 December 2020

Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma

1 reference

12 December 2020

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

1 reference

12 December 2020

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma

1 reference

12 December 2020

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

12 December 2020

Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy: evaluation with FDG PET

1 reference

12 December 2020

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT

1 reference

12 December 2020

Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

1 reference

12 December 2020

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy

1 reference

12 December 2020

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

1 reference

12 December 2020

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma

1 reference

12 December 2020

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

12 December 2020

Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma

1 reference

12 December 2020

Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma

1 reference

12 December 2020

Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy

1 reference

12 December 2020

Problems in Hodgkin's disease management

1 reference

12 December 2020

Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

1 reference

12 December 2020

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation

1 reference

12 December 2020

Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose

1 reference

12 December 2020

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

1 reference

12 December 2020

Response of mediastinal Hodgkin's disease to radiotherapy: rate of tumor regression not predictive of outcome

1 reference

12 December 2020

The role of positron emission tomography (PET) in the management of lymphoma patients

1 reference

12 December 2020

Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography

1 reference

12 December 2020

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

1 reference

12 December 2020

Assessment of Lymphoma Therapy Using (18)F-FDG PET.

1 reference

12 December 2020

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

1 reference

12 December 2020

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

12 December 2020

How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients?

1 reference

12 December 2020

Identifiers

1 reference

6 August 2017

1 reference